Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PHOSPHORUS Cause Product use in unapproved indication? 175 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Product use in unapproved indication have been filed in association with PHOSPHORUS (Phosphorus). This represents 54.2% of all adverse event reports for PHOSPHORUS.

175
Reports of Product use in unapproved indication with PHOSPHORUS
54.2%
of all PHOSPHORUS reports
128
Deaths
65
Hospitalizations

How Dangerous Is Product use in unapproved indication From PHOSPHORUS?

Of the 175 reports, 128 (73.1%) resulted in death, 65 (37.1%) required hospitalization, and 66 (37.7%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PHOSPHORUS. However, 175 reports have been filed with the FAERS database.

What Other Side Effects Does PHOSPHORUS Cause?

Paraesthesia (233) Hypoaesthesia (225) Abdominal pain upper (204) Vomiting (200) Taste disorder (199) Drug intolerance (198) Blepharospasm (197) Epilepsy (196) Gastrooesophageal reflux disease (196) Drug ineffective (185)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which PHOSPHORUS Alternatives Have Lower Product use in unapproved indication Risk?

PHOSPHORUS vs PHTHALYLSULFATHIAZOLE PHOSPHORUS vs PHYTONADIONE PHOSPHORUS vs PICATO PHOSPHORUS vs PIFLUFOLASTAT F-18 PHOSPHORUS vs PILOCARPINE

Related Pages

PHOSPHORUS Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication PHOSPHORUS Demographics